The Wharton Moneyball Post Game Podcast


Wharton Moneyball Podcast: NBA Analytics & Shane Battier of the Miami Heat

Ep. 137

Show from 2/13/19

In this episode of Wharton Moneyball all of our hosts are in the studio and kick off the show talking NBA trade, the 76ers vs Celtics game, and e-sports. Then they bring on Neil Paine of FiveThirtyEight to talk basketball as well as Lindsey Vonn becoming the greatest American skier! Plus we have a special guest on the program, Shane Battier of the Miami Heat! He gets into the intersection of analytics and culture in the NBA. He also talks about his time as a player and an analyst working with Kobe Bryant, LeBron James, and Kevin Durant! Last, but not least, our hosts reflect on their past 'Over/ Under' bets to see who came out on top and who needs to hit the numbers again. Tune in!


Neil Paine - A longtime friend of the show as well as a Senior Writer and General Editor at FiveThirtyEight. He covers a wide range of sports, with a focus on sabermetrics and statistical analysis.

Follow him on Twitter @Neil_Paine 

Shane Battier - He is in his second season as Vice President of Basketball Development & Analytics with the Miami Heat. His responsibilities involve the development of analytics to evaluate all talent, including college, free agents and current Miami players. He played three seasons with the HEAT and helped bring the franchise back-to-back NBA championships. In all, he played 13 seasons in the NBA as well as four seasons at Duke, where he was named National Player of the Year.

Follow him on Twitter @ShaneBattier

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.